Categories
Divergent News Healthcare & Wellness

FDA review finds no increased risk of prostate cancer with Parkinson’s disease medicines containing entacapone (Comtan, Stalevo) | FDA

FDA Drug Safety Communication Source: FDA review finds no increased risk of prostate cancer with Parkinson’s disease medicines containing entacapone (Comtan, Stalevo) | FDA